WHO ICTRP trial
An Open Label Study of the use of Aripiprazole in the Treatment of Chronic Post…
ACTRN12605000322639 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12605000322639 |
|---|---|
| Public title | An Open Label Study of the use of Aripiprazole in the Treatment of Chronic Post Traumatic Stress Disorder |
| Scientific title | A pilot Open Label Study of Aripiprazole as Add On Therapy in Post Traumatic Stress disorder as measured by impact on CAPS-2 scores |
| Primary sponsor | Austin Health |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Australia |
| Conditions | Post Traumatic stress Disorder; Post Traumatic stress Disorder;Mental Health - Other mental health disorders |
| Interventions | 8 week Open label prescription of Aripiprazole, in addition to any current anti-depressant therapy. |
| Registration date | Jun 9, 2005 |
| Target size | 20 |
| Secondary IDs | Nil known |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: